Dr. Gabi Tarcic is the Vice President of Product at Evogene (Nasdaq/TASE: EVGN), bringing over a decade of leadership experience in biotechnology. With a Ph.D. in life sciences from The Weizmann Institute of Science, he has held senior roles in research and development, including Chief Technology Officer at Fore Biotherapeutics. Since joining Evogene in September 2024, Gabi has been focused on advancing the company’s AI-driven drug discovery efforts through its proprietary ChemPass AI engine, combining his scientific expertise with product leadership to drive innovation in biotech.
In this episode, Gabi shares how Evogene leverages computational chemistry and AI to tackle the complex challenge of developing new drugs, explaining how their platform enables the generative design of novel small molecules optimized for safety and effectiveness. He reflects on his personal career journey from academic research to applied product strategy, highlighting the evolving mindset required to bring real-world impact. While AI plays a powerful role, Gabi emphasizes that human insight remains essential, especially in navigating ethical and regulatory demands. He also discusses how Evogene applies its technology across both pharmaceutical and agricultural industries, and offers practical advice for startups working with AI in biotech. Throughout, Gabi takes a realistic view of the industry’s slow pace and the importance of patience and adaptability as AI continues to shape the future of drug development.
